Brookfield stock
BNNYSEBrookfield Corporation, Financial ServicesISIN CA11271J1075
46Score 46 out of 100, Weak
Price and trend
63 / 100
Price history
−11% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 1.6% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 65).
The price is 15% below its 52-week high. Largest decline in 20 years: 73% (May 2007 to March 2009).
Chart figures for advanced users
- SMA 50$38.33
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$42.34
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)65
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$35.95
- The lowest closing price of the last twelve months.
- Resistance$49.17
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Brookfield Corporation belongs to the Asset Management industry (Canada) and, with a market value of $92.96B, is number 4 of 131 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $76.13B (down 11.5% year on year) and earnings of $1.31B (up 103.9%).
- MEQIRI Score 46 out of 100 (Weak): rank 890 of 976 in Financial Services, median 68.
Show more
- The P/E is 74 (Asset Management median 14, own median of recent years 25.6).
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Richly valuedP/E 74, Asset Management median 14, own median 25.6.Valuation 10
- Low return on equityReturn on equity 3% over the last 12 months.Profitability 21
Its standout strength is stability, while profitability and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among stocks ranked 101 to 1,000.
From 2016 to 2025, 13 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
Valuation
Valuation signal
OvervaluedClosing price of 11 Nov 2026, used by the daily score.
A fair value is not meaningful here, so the signal follows the valuation grade.
Valuation metrics
The model puts the fair value at less than a quarter of the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 2.2% on the twelve months before. Revenue has grown strongly since 2006, at around 13% per year.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 29%, net 2%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 11 Feb 2027in 91 days
- Last reported
- 12 Nov 2026EPS reported $0.64 (expected $0.68)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $2.75+1.7%
- Revenue
- $7.23B−1.8%
- Earnings per share
- $3.39+1.6%
- Revenue
- $8.87B−2.6%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −1.9%At the group level the outlook is described as largely consistent with recent comments, with a strong investment pipeline and a growing annuity market.
“Second, on the investment side, we have started bringing Brookfield's origination capabilities into the portfolio with a strong investment pipeline for the remainder of the year that we expect to drive further growth into our investment yields, our spreads and the returns on the overall business.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 13 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Brookfield
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
976 rated companies in Financial Services
- This company
- 46
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Asset Management
The next larger and next smaller companies by market value
- BlackRockBLK $189.37B71
- BlackstoneBX $142.21B80
- InvestorINVE-B.ST $134.27B84
- KKRKKR $89.81B58
- Brookfield Asset ManagementBAM $83.98B63
- Apollo Global ManagementAPO $72.61B46
- State StreetSTT $47.39B73
- Ares ManagementARES $45.29B66
ETFs that hold Brookfield
Held by 48 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Listed Private Equity UCITS ETFIQQL | 8.17% | 0.75% | €683.78M |
| Xtrackers MSCI Canada Screened UCITS ETF 1CD5BH | 2.77% | 0.35% | €1.2B |
| iShares MSCI Canada UCITS ETFSXR2 | 2.69% | 0.48% | €2.15B |
Show 5 more
| UBS MSCI Canada UCITS ETF CAD disUIM9 | 2.52% | 0.33% | €2.06B |
| Xtrackers MSCI World Financials UCITS ETF 1CXDWF | 0.56% | 0.25% | €1.44B |
| iShares MSCI World ex-USA UCITS ETF USD (Acc)IXUA | 0.35% | 0.15% | €3.41B |
| iShares MSCI North America UCITS ETFIQQN | 0.13% | 0.40% | €1.37B |
| Invesco FTSE All-World UCITS ETF USDFTWD | 0.12% | 0.15% | €4.75B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 21 Feb 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.